Fig. 3From: Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methodsCost-effectiveness acceptability curves for the trial and lifetime time horizonsBack to article page